0
Department of Health and Human Services Awarded a Contract to MAPP BIOPHARMACEUTICAL, INC. for $906,651,397.58
Signed on
9/27/2022, 12:00 AM
MAPP BIOPHARMACEUTICAL, INC. Government Contract #75A50122C00061
MAPP BIOPHARMACEUTICAL, INC. was awarded a contract with the United States Government for $906,651,397.58. The contract was awarded by the agency office BARDA - ASPR / DAAPPO / BARDA DCMA, which is a division with the Office of Assistant Secretary for Preparedness and Response within the Department of Health and Human Services.
Summary of Award
The recipient of the federal contract is MAPP BIOPHARMACEUTICAL, INC., a U.S.-owned small business located in San Diego, California. The contract, awarded by the Department of Health and Human Services, is for procurement of therapeutics for Ebola, Sudan, and Marburg viruses, with a total value of $184,786,390.58. The contract involves research and development in biotechnology. Notable spending patterns include a total account obligation of $134,839,788.58 and total outlays of $74,661,963.25.